Towards Healthcare
Softgel Capsules Market to Expand USD 17.59 Bn by 2034

Softgel Capsules Market 2025 Insights North America Leads with 38% Share, Asia-Pacific Fastest Growing Region

Projections indicate that, the global softgel capsules market will increase from USD 9.88 billion in 2024 to USD 17.59 billion by 2034, experiencing a CAGR of 5.94% over the next 10 years. Rising demand for nutritional supplements has driven the growth of the softgel capsules market over the forecast period. North America led the global market owing to the growing senior population requiring easy-to-swallow dosage forms in the region. 

Content

  • Insight Code: 6015
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The softgel capsules market is valued at USD 10.47 billion in 2025 and is on track to reach USD 17.59 billion by 2034, witnessing a steady CAGR of 5.94% during the forecast span.

North America is currently leading the softgel capsules market due to a stringent regulatory environment & consumer trust, prevalence of chronic diseases & rising supplement use.

he softgel capsules market includes 6 segments such as by type, by application, by manufacturing technology, by end user, by distribution channel, and by region.

Some key players include Catalent, Inc., Aenova Group, EuroCaps Ltd., Sirio Pharma Co., Ltd., Lonza Group AG, BASF SE, Fuji Capsule Co., Ltd., Procaps Group, Soft Gel Technologies, Inc., Strides Pharma Science Limited, and Robinson Pharma, Inc., among others.

Ministry of Health and Family Welfare, Indian Drug Manufacturers Association IDMA, Government of India, National Institutes of Health, Pharmaceutical Manufacturers Association, FDA, WHO, Chemical Pharmacy Associations, PIB, BDMAI Bulk Drug Manufacturers Association of India, and CDC.
Any Questions